• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

2-(2-Bromophenyl)-4-(Chloromethyl)-1,3-Oxazole: A Comprehensive Overview

2-(2-Bromophenyl)-4-(Chloromethyl)-1,3-oxazole (CAS No. 1038295-04-3) is a versatile organic compound with a unique structure that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its brominated and chlorinated functionalities, offers a range of potential applications in drug discovery and development. This article provides an in-depth exploration of the chemical properties, synthesis methods, biological activities, and recent advancements in the study of 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole.

Chemical Structure and Properties

The molecular formula of 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole is C₁₀H₈BrClN₂O, with a molecular weight of approximately 267.54 g/mol. The compound features a 1,3-oxazole ring system, which is a five-membered heterocyclic ring containing one oxygen and one nitrogen atom. The presence of the bromine and chlorine substituents imparts unique chemical and physical properties to the molecule. These halogen atoms can participate in various chemical reactions, such as nucleophilic substitution and cross-coupling reactions, making 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole a valuable building block in organic synthesis.

Synthesis Methods

The synthesis of 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole can be achieved through several well-established routes. One common method involves the reaction of 2-bromobenzaldehyde with chloroacetonitrile in the presence of a base to form the corresponding nitrile oxide intermediate. This intermediate then undergoes intramolecular cyclization to yield the desired oxazole compound. Another approach involves the reaction of 2-bromobenzoyl chloride with chloroacetonitrile followed by cyclization under appropriate conditions. Recent advancements in green chemistry have also led to the development of more environmentally friendly synthetic methods, such as microwave-assisted synthesis and solvent-free conditions.

Biological Activities and Applications

2-(2-Bromophenyl)-4-(chloromethyl)-1,3-oxazole has been investigated for its potential biological activities and therapeutic applications. Studies have shown that this compound exhibits significant antimicrobial properties against various bacterial strains, including both Gram-positive and Gram-negative bacteria. The bromine and chlorine substituents are believed to play a crucial role in enhancing the compound's antibacterial activity by disrupting cell membrane integrity and inhibiting essential metabolic pathways.

In addition to its antimicrobial properties, 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole has also been explored for its anticancer potential. Research has demonstrated that this compound can induce apoptosis in cancer cells by modulating key signaling pathways involved in cell proliferation and survival. Specifically, it has been shown to inhibit the activity of certain kinases and transcription factors that are often dysregulated in cancer cells.

Clinical Trials and Future Prospects

The promising biological activities of 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole have led to increased interest in its clinical evaluation. Several preclinical studies have been conducted to assess the safety and efficacy of this compound in various disease models. These studies have provided valuable insights into the pharmacokinetic and pharmacodynamic properties of the molecule, paving the way for further clinical trials.

In recent years, there has been a growing focus on developing targeted therapies for specific diseases. The unique structure of 2-(2-bromophenyl)-4-(chloromethyl)-1,3-oxazole, with its halogenated functionalities, makes it an attractive candidate for such approaches. Researchers are exploring ways to modify the compound to enhance its selectivity and reduce potential side effects. For example, conjugation with targeting moieties or encapsulation in nanocarriers can improve drug delivery and bioavailability.

Conclusion

2-(2-Bromophenyl)-4-(chloromethyl)-1,3-oxazole (CAS No. 1038295-04-3) is a multifaceted organic compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure, coupled with its promising biological activities, makes it an important molecule for further investigation. As research continues to advance, it is likely that new insights into the properties and applications of this compound will emerge, potentially leading to novel therapeutic strategies for various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)